Displaying One Session
Industry Satellite Symposium
Date
22.09.2020
Chairs
- Sandra M. Swain (Washington, DC, United States of America)
F. Hoffmann-La Roche - Advancing Knowledge in Early and Metastatic Triple-Negative Breast Cancer
Industry Satellite Symposium
The biology of breast cancer: Lessons from the past (ID 5416)
Speakers
- Sandra M. Swain (Washington, DC, United States of America)
F. Hoffmann-La Roche - Advancing Knowledge in Early and Metastatic Triple-Negative Breast Cancer
Industry Satellite Symposium
Raising the bar in early TNBC (ID 5417)
Speakers
- Peter Schmid (London, United Kingdom)
F. Hoffmann-La Roche - Advancing Knowledge in Early and Metastatic Triple-Negative Breast Cancer
Industry Satellite Symposium
Insights from the clinic: Hypothetical eTNBC Patient Scenario(s) (ID 5418)
Speakers
- Carlos H. Barrios (Porto Alegre, Brazil)
F. Hoffmann-La Roche - Advancing Knowledge in Early and Metastatic Triple-Negative Breast Cancer
Industry Satellite Symposium
New frontiers in metastatic TNBC (ID 5419)
Speakers
- Rebecca Dent (Singapore, Singapore)
F. Hoffmann-La Roche - Advancing Knowledge in Early and Metastatic Triple-Negative Breast Cancer
Industry Satellite Symposium
Insights from the clinic: Hypothetical mTNBC Patient Scenario(s) (ID 5420)
Speakers
- Carlos H. Barrios (Porto Alegre, Brazil)
F. Hoffmann-La Roche - Advancing Knowledge in Early and Metastatic Triple-Negative Breast Cancer
Industry Satellite Symposium
Looking at the future horizon (ID 5421)
Speakers
- Sandra M. Swain (Washington, DC, United States of America)
F. Hoffmann-La Roche - Advancing Knowledge in Early and Metastatic Triple-Negative Breast Cancer
Industry Satellite Symposium
Live Q&A - 22 September 2020 - 16:15-16:45 (ID 5502)
Speakers
- Sandra M. Swain (Washington, DC, United States of America)